Delivery Order SPE2DB24D1007-SPE2DB24FBYXX
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,052.41 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract has a completion date of February 9, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a potential value of $1,176.68 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
- The Defense Logistics Agency (DLA) awarded a $3,195.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a potential value of $2,685.51 and a completion date of February 12, 2024. This award is not associated with any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ENGERIX-B 20 MCG/ML VIALML, a pharmaceutical product, with a potential value of $1,820.64 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and there...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $76,007.40. This delivery order contract has an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and the award does not have a set-aside designation. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, SPE2DB22D1002|SPE2DB24FLAE6, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,158,341 units of the pharmaceutical product ENGERIX-B 20 MCG/ML SYRNML. The contract has a ceiling value of $1,677.10 and a period of performance through April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B 20 MCG/ML VIALML pharmaceutical products. The $1,820.64 delivery order has a completion date of January 17, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has previously supplied pharmaceuticals, medical supplies, and distribution services to support DLA programs. This delivery order...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B 20 MCG/ML VIAL/ML pharmaceutical products. The $1,840.57 award has a completion date of February 23, 2024 and was issued on February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this order. Amerisourcebergen Drug Corp holds an...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract valued at $5,850.10 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical product. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was awarded solely to Amerisourcebergen Drug Corp. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB24FBYXXDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, at a firm fixed price of $2,368.60. The order has a period of performance through March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the order is not associated with any set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 3/25/24 |